Paid Clinical Trials Kentucky
Discover 975 paid clinical trials in Kentucky. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Observational StudyRegistry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction
Sponsor:
Axogen Corporation
Location:
Code:
NCT01526681
Conditions
Peripheral Nerve Injuries
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Processed Human Nerve Graft
Standard Treatment, Autogenous Nerve Graft, Direct Suture, etc.
Autogenous Nerve Graft
Nerve Tube Conduit
Autologous Breast Reconstruction with Neurotization
Remibrutinib vs. TeriflunomideEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT05156281
Conditions
Relapsing Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Not accepted
Interventions
Remibrutinib
Teriflunomide
BT8009Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
Sponsor:
BicycleTx Limited
Location:
Code:
NCT04561362
Conditions
Urinary Bladder Neoplasm
Triple Negative Breast Neoplasms
Hormone Receptor Positive, HER2-negative Neoplasms
Hormone Receptor Positive, HER2-low Neoplasms
Breast Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BT8009
Pembrolizumab
LY3556050A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT06074562
Conditions
Diabetic Peripheral Neuropathy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LY3556050
Placebo
TMSTranscranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH
Sponsor:
Gopalkumar Rakesh
Location:
Code:
NCT06830980
Conditions
Methamphetamine Use Disorders
HIV
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
intermittent theta burst stimulation (iTBS)
continuous theta burst stimulation (cTBS)
Sham TMS
OSA TherapyReiterative Development and Evaluation Study of OSA Therapy System
Sponsor:
ApniCure, Inc.
Location:
Code:
NCT01634074
Conditions
Obstructive Sleep Apnea
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
GIM-122Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies
Sponsor:
Georgiamune Inc
Location:
Code:
NCT06028074
Conditions
Advanced Solid Malignancies
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
GIM122
Immunotherapy & Irreversible ElectroporationImmunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
Sponsor:
University of Louisville
Location:
Code:
NCT03080974
Conditions
Pancreatic Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nivolumab
Irreversible Electroporation
177Lu-DOTATATE vs. EverolimusComparing Retreatment of 177Lu-DOTATATE PRRT Versus Everolimus in Patients With Metastatic Unresectable Midgut Neuroendocrine Tumors, NET RETREAT Trial
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05773274
Conditions
Metastatic Midgut Neuroendocrine Tumor
Metastatic Midgut Neuroendocrine Tumor G1
Metastatic Midgut Neuroendocrine Tumor G2
Unresectable Midgut Neuroendocrine Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Computed Tomography
Everolimus
Lutetium Lu 177 Dotatate
Quality-of-Life Assessment
NNC0487-0111A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes
Sponsor:
Novo Nordisk A/S
Location:
Code:
NCT06542874
Conditions
Type 2 Diabetes (T2D)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
NNC0487-0111 subcutanous
Placebo (NNC0487-0111 subcutanous)
NNC0487-0111 oral
Placebo (NNC0487-0111 oral)